|
DCLRE1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22599999999407E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26779999998217E-06 |
| Normal-vs-Stage2 |
1.015180E-01 |
| Normal-vs-Stage3 |
2.330200E-01 |
| Normal-vs-Stage4 |
9.719800E-01 |
| Stage1-vs-Stage2 |
3.249800E-01 |
| Stage1-vs-Stage3 |
7.320100E-02 |
| Stage1-vs-Stage4 |
4.718000E-02 |
| Stage2-vs-Stage3 |
6.424800E-01 |
| Stage2-vs-Stage4 |
3.108800E-01 |
| Stage3-vs-Stage4 |
5.055000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47989999999643E-05 |
| Normal-vs-AfricanAmerican |
8.940800E-03 |
| Normal-vs-Asian |
2.894200E-02 |
| Caucasian-vs-AfricanAmerican |
5.826800E-01 |
| Caucasian-vs-Asian |
8.695400E-01 |
| AfricanAmerican-vs-Asian |
7.344000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88440000048473E-07 |
| Normal-vs-Female |
4.265200E-01 |
| Male-vs-Female |
8.016400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.344900E-03 |
| Normal-vs-Extreme_Weight |
1.80600000510012E-08 |
| Normal-vs-Obese |
1.943540E-02 |
| Normal-vs-Extreme_Obese |
6.096500E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.417400E-01 |
| Normal_Weight-vs-Obese |
2.727200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.310600E-01 |
| Extreme_Weight-vs-Obese |
1.347860E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.454000E-01 |
| Obese-vs-Extreme_Obese |
5.655000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.802400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.357700E-03 |
| Normal-vs-Age(61-80Yrs) |
8.16270000036923E-07 |
| Normal-vs-Age(81-100Yrs) |
2.34419999999291E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.400100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.082300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.621400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.267700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.818400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.236400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.32640000041862E-07 |
| Normal-VS-Type2 PRCC |
5.156700E-03 |
| Normal-VS-KIRP CIMP |
3.171400E-01 |
| Normal-VS-Unclassified PRCC |
6.185800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.404380E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.644620E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.728300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.502100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.690780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.420400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.622800E-04 |
| Normal-vs-N1 |
5.420400E-01 |
| Normal-vs-N2 |
1.238840E-01 |
| N0-vs-N1 |
3.055600E-03 |
| N0-vs-N2 |
7.865400E-01 |
| N1-vs-N2 |
3.121800E-01 |
|
|
